News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. annual CPI rose to 3.8% in April, lifting bond yields and pulling the S&P 500 and Nasdaq lower.
  • Semiconductor stocks plunged, weighing on the Nasdaq and accelerating the broader equities sell-off.
  • American Electric Power arranged a $2.6 billion equity offering via two-year forward sales, and shares fell about 3% after-hours.
  • FCC approved EchoStar's $40 billion wireless-spectrum sale to SpaceX and AT&T, adding build conditions and a $2.4 billion escrow.
  • Anthropic is seeking at least $30 billion in funding at a pre-money valuation above $900 billion while exploring an October IPO.
  • USDA excluded ten lenders from its Rural Development program over compliance, removing roughly $620 million in delinquent-loan exposure.
  • S&P moved Mexico's outlook to negative while maintaining BBB ratings, citing fiscal strain and state-energy support risks.

Latest Articles

Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer

Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer

Humacyte, Inc., a Nasdaq-listed biotech company specializing in bioengineered human tissues, announced the appointment of Dr. Todd E. Rasmussen, a distinguished vascular surgeon, as Chief Surgical Officer. Dr. Rasmussen brings extensive clinical expertise and leadership to support the clinical use and adoption of Humacyte’s flagship product Symvess…

Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology

Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology

Rhythm Pharmaceuticals announced new data presentations highlighting the efficacy of its drug setmelanotide in treating acquired hypothalamic obesity (HO) and Bardet-Biedl syndrome (BBS). Real-world data from France demonstrated significant and sustained BMI reductions in adults with acquired HO over 12 months. Phase 3 analyses showed improvements …

SunPower Reports Q1’26 Results

SunPower Reports Q1’26 Results

SunPower Inc. reported preliminary unaudited Q1 2026 results with revenue of $72.8 million, a 9% decline from Q4 2025, and a non-GAAP operating loss of $12.9 million due to revenue shortfall and increased spending in anticipation of Q3 growth. The company completed its 2025 10K audit with required restatements of prior quarterly reports due to acco…

Apollo Funds Acquire Majority Stake in Noble Environmental, Inc.

Apollo Funds Acquire Majority Stake in Noble Environmental, Inc.

Apollo-managed funds have acquired a majority interest in Noble Environmental, a vertically integrated waste management company operating in the Northeast, Mid-Atlantic, and Midwest United States. The acquisition emphasizes Apollo's commitment to investing in essential service businesses with long-life hard assets and growth potential, including No…

SPAR Group, Inc. Reports First Quarter Fiscal 2026 Results

SPAR Group, Inc. Reports First Quarter Fiscal 2026 Results

SPAR Group, Inc. reported first quarter fiscal 2026 results showing a 10% year-over-year revenue decline primarily due to reduced US Remodel business, but achieved higher gross margins at 22.3% and returned to positive EBITDA. The company strategically shifted its focus toward higher-margin recurring merchandising revenue, resulting in U.S. Merchan…

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

Nuwellis, Inc. announced its Q1 2026 financial results showing a 26% increase in net sales to $2.4 million and gross margin improvement to 70.1%. The company completed the acquisition of Rendiatech, enhancing its cardiorenal monitoring capabilities, secured new U.S. patents, and expanded commercial coverage. These developments mark progress in its …

Aptera Motors Drives First Five Validation Vehicles Off the Line

Aptera Motors Drives First Five Validation Vehicles Off the Line

Aptera Motors has successfully completed assembly of its first five validation vehicles at its Carlsbad, California facility, marking a key milestone in its transition from development to production. The low-volume validation assembly line allows continuous improvement of manufacturing processes, supporting the company's mission to deliver ultra-ef…

Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development

Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development

Incannex Healthcare Inc., a Nasdaq-listed biopharmaceutical company, announced it has won the 'Best New Technology Solution for Drug Development' award at the MedTech Breakthrough Awards for its lead drug candidate IHL-42X. This oral fixed-dose combination therapy targets obstructive sleep apnea and has shown positive Phase 2 clinical results. The …

Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

Gelteq Limited announced a strategic debt financing round worth up to $3.5 million aimed at accelerating commercialization efforts, expanding clinical trial activity, and supporting revenue growth. The funds will be used to scale clinical programs and ramp up sales across key markets, enhancing operational scalability and market adoption of its pro…

TON Strategy Company Reports First Quarter 2026 Financial Results

TON Strategy Company Reports First Quarter 2026 Financial Results

TON Strategy Company announced their Q1 2026 financial results showing $5.3 million revenue, including $3.0 million from staking Toncoin, though reporting an overall net loss driven by unrealized asset depreciation. They hold approximately 222 million Toncoin tokens representing 4.29% of all Toncoin, with significant staking usage in the network. R…

eToro Tops Q1 Profit Forecasts as Commodities Trading Fuels Revenue Gain

eToro Tops Q1 Profit Forecasts as Commodities Trading Fuels Revenue Gain

eToro reported an adjusted profit above analyst expectations for the first quarter, driven by a pronounced increase in commodities trading activity. The retail trading platform recorded a sharp rise in net trading contribution across equities, commodities and currencies, and introduced around-the-clock trading for several asset classes during the q…

Hims & Hers Shares Slide After Q1 Revenue and EBITDA Fall Short of Estimates

Hims & Hers Shares Slide After Q1 Revenue and EBITDA Fall Short of Estimates

Hims & Hers Health Inc. stock dropped sharply after the company reported first-quarter results that missed Wall Street expectations on both revenue and adjusted EBITDA. Revenue rose modestly year-over-year but fell short of consensus and BTIG estimates, while adjusted EBITDA declined dramatically versus the prior year, prompting analyst concerns ab…

Diana Shipping Inc. Launches Campaign Website in Connection with Effort to Unlock Immediate Value at Genco Shipping & Trading

Diana Shipping Inc. Launches Campaign Website in Connection with Effort to Unlock Immediate Value at Genco Shipping & Trading

Diana Shipping Inc., a public US-listed dry bulk shipping company, has launched www.CashforGenco.com to support its campaign to elect six independent directors to Genco Shipping & Trading's board. Diana owns approximately 14.7% of Genco and has made an all-cash acquisition offer of $23.50 per share, representing a 31% premium. Diana highlights alle…

India Sees Drop in Urals Crude Premiums as Refiners Scale Back Buying

India Sees Drop in Urals Crude Premiums as Refiners Scale Back Buying

Premiums for Russia's Urals crude destined for Indian ports have fallen for June delivery as refiners cut back purchases in response to weakening refining margins. The margin-driven pullback has trimmed Urals' premium to Brent to $2-$4 a barrel from $6-$7 for May cargoes, while similar softening is visible for Russia's ESPO Blend shipments to China…